ANNOUNCEMENT

Save $300 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Earlybird rate ends May 20.

Sleep apnea treatment company Apnex Medical developing an implantable device raises $10M

September 24, 2012 11:10 am by | 0 Comments

Company name: Apnex Medical.

Industry: medical devices.

Location:St. Paul, Minnesota.

Solution/product:The ApnexHypoglossal Nerve Stimulation system is an implantable therapy able to detects the patient’s breathing pattern during sleep and provides mild electric pulses to the hypoglossal nerve that controls the muscles that keep airways open.

Money raised:$10 million in this round; more than $50 million in additional rounds previously, according to regulatory filings.

How it will be used:The money will fund the continuation of a randomized clinical study whose results are expected to support Apnex Medical’s premarket approval application to the U.S. Food and Drug Administration for the implanted therapy.

Investors:New Enterprise Associates; previous investors areDomain Associates, Polaris Ventures and Michael Berman, a Minnesota-based medical device industry investor and serial entrepreneur.

Management team:It appears that Charles McKhann is no longer CEO, based on the news release, which instead names Robert Atkinson, the founder of Apnex, as president and CEO. (However, the website still indicates that McKhann leads the company and a call and email to a spokeswoman was not immediately returned.) Other executives are Steve Bolea, vice president of R&D, and Ginny Kirby, vice president of clinical and regulatory affairs.

Market: Apnex has two main competitors. Inspire Medical Systems, based in Minnesota, has an implantable therapy that, like Apnex, targets the hypoglosssal nerve. ImThera Medical of San Diego also delivers neurostimulation like Apnex and Inspire, but it targets multiple muscles and nerves in the tongue. The Sleep Foundation estimates that 18 million people have sleep apnea in the U.S.

Apnex Medical, which is testing its implantable device to treat obstructive sleep apnea announced Monday that it has raised $10 million. Here are the details of the funding:

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Arundhati Parmar

By Arundhati Parmar

Arundhati Parmar is the Medical Devices Reporter at MedCity News. She has covered medical technology since 2008 and specialized in business journalism since 2001. Parmar has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.
More posts by Author

0 comments

Stay Up To Date

Recent Comments

Research Center

Jobs Board

Next Story
A mom-inspired device could let kids with asthma take their daily meds while they sleep
Close